The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration

October 27, 2023 updated by: Nourhan M.Aly

The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration: A Randomized Controlled Clinical Trial

This study aims to investigate the influence of desensitizing agents on reducing post-operative sensitivity in posterior composite.

Study Overview

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt
        • Faculty of Dentistry, Alexandria University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients having active primary class I carious lesions on vital molar teeth either in the middle or the inner third of dentin in the three quadrants of each patients.
  • Teeth having a positive reaction to vitality test (cold test), no signs of pulp inflammation, or spontaneous pain before treatment.
  • Preoperative radiographic record of the carious lesions.
  • Buccolingual width is no more than half the inter-cuspal distance

Exclusion Criteria:

  • Excessive tooth wear due to clenching or abnormal habits.
  • Patients with direct occlusal contact by antagonist cusp (traumatic occlusion).
  • Patients with periodontal or gingival disease.
  • Patients using analgesics and/or anti-inflammatory medicine.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Composite with Hurriseal desensitizer

Patients will receive Hurriseal desensitizing agent and universal bond and composite.

Cavities will be restored with light-cured composite resin following the application of bonding agent.

Active Comparator: Composite with Gluma Desensitizer

Patients will receive Gluma desensitizing agent and universal bond and composite.

Cavities will be restored with light-cured composite resin following the application of bonding agent.

No Intervention: Composite without desensitizer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hypersensitivity assessment
Time Frame: up to 12 months
Air spray will be applied from a 2-mm distance on to the occlusal for 3 seconds. The severity of patients' pain/sensitivity will be recorded using (0-10) numerical rating scale. The score will be ranged from 0 (No pain) to 10 (maximum pain)
up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Nessrin Magdy, BDS, Alexandria University
  • Study Director: Waleed El-Mahy, PhD, Alexandria University
  • Study Chair: Rania R Afifi, PhD, Alexandria University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 5, 2022

Primary Completion (Actual)

August 5, 2023

Study Completion (Actual)

August 30, 2023

Study Registration Dates

First Submitted

October 27, 2023

First Submitted That Met QC Criteria

October 27, 2023

First Posted (Actual)

November 2, 2023

Study Record Updates

Last Update Posted (Actual)

November 2, 2023

Last Update Submitted That Met QC Criteria

October 27, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 7/22

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dentin Hypersensitivity

Clinical Trials on Hurriseal desensitizer

3
Subscribe